The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishibashi, K.
Right arrow Articles by Hashimoto, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishibashi, K.
Right arrow Articles by Hashimoto, S.

The Journal of Immunology, Vol 139, Issue 5 1509-1513, Copyright © 1987 by American Association of Immunologists


ARTICLES

Expression of HTLV-I in serum of HTLV-I-related subjects and the early detection of overt ATL in HTLV-I carriers

K Ishibashi, S Hanada and S Hashimoto

Monoclonal antibodies against human T cell leukemia virus type I (HTLV- I) p24 and p19 were produced and employed in the in vivo expression of HTLV-I in some HTLV-I-related subjects by Western blot analysis. The antigenic determinants of these monoclonal antibodies were different from that of natural human anti-HTLV-I antibody examined. Serum p24 was identifiable in almost all of the overt ATL patients (17 of 18, 94%), but not in the chronic ATL cases or HTLV-I carriers. On the other hand, serum p19 was detected in one of the three patients with chronic ATL examined, but not in the overt ATL patients or the HTLV-I carriers. These results indicate that the in vivo expression of HTLV-I p24 and p19 which has reacted with natural anti-HTLV-I antibody can be detected by these monoclonal antibodies. Therefore, the investigation of serum HTLV-I expression may lead to the early detection of overt ATL in an HTLV-I carrier.


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
B. A. Lenzmeier, H. A. Giebler, and J. K. Nyborg
Human T-Cell Leukemia Virus Type 1 Tax Requires Direct Access to DNA for Recruitment of CREB Binding Protein to the Viral Promoter
Mol. Cell. Biol., February 1, 1998; 18(2): 721 - 731.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Brauweiler, P. Garl, A. A. Franklin, H. A. Giebler, and J. K. Nyborg
A Molecular Mechanism for Human T-cell Leukemia Virus Latency and Tax Transactivation
J. Biol. Chem., May 26, 1995; 270(21): 12814 - 12822.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.